Digital-Health-Glossary-IGR-PV-Topic-8-_final_version01

Related Blog Posts

The Impact of ICH E6(R3) – Sponsor and CRO Perspectives

Digital-Health-Glossary-IGR-PV-Topic-8-_final_version01 In ACRO and TransCelerate BioPharma’s latest collaboration, Cris McDavid (Senior Director, Global Clinical Operations, Parexel) and Tashan Mistree (Senior Director, Business Operations, Office of Chief Medical Officer, GSK) join this week’s episode to discuss the impact of ICH E6(R3) from their different vantage points in the clinical research industry. Listen to the podcast by Cris McDavid and Tashan…

Unifying Industry to Better Understand GCP Guidance

Digital-Health-Glossary-IGR-PV-Topic-8-_final_version01 In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better…

Closing the Evidence Gap in Women’s Health – the Need for Inclusive Clinical Research

Digital-Health-Glossary-IGR-PV-Topic-8-_final_version01 For decades, women were significantly underrepresented in clinical trials. Recent years have seen improvement, but there are lingering gaps in our collective understanding of how therapies work across sexes, life stages, health conditions and care settings. Read the full article by Jeneen Donadeo from PharmaTimes here.